Lyme disease vaccine for humans being given to male patient
Lyme Science Blog
Sep 18

Lyme Vaccine for Humans: What Happened to LYMErix?

Comments: 8
Like
Visited 545 Times, 1 Visit today

Lyme Vaccine for Humans: What Happened to LYMErix?

Human Lyme vaccines remain controversial
LYMErix changed the vaccine conversation
Safety and trust still shape adoption

The discussion around a Lyme vaccine for humans did not end when LYMErix disappeared from the market. Many patients continue to ask whether a future Lyme vaccine will be more effective, safer, and better accepted.

For others, the question remains simple: what happened to LYMErix?

LYMErix was reportedly effective at preventing an erythema migrans rash. However, according to the LYMErix package insert, protection against other manifestations of Lyme disease was more limited, with effectiveness estimates around 50% for some outcomes.

LYMErix was voluntarily removed from the market because of low demand.

In a survey of 1,015 adults in the United States, author Matt Motta examined how likely individuals were to request vaccination if a Lyme vaccine became available for public use.1

The study found that individuals living in regions where Lyme disease is common were more likely to consider vaccination, while lower trust in scientific institutions reduced vaccine acceptance.1

What happened to LYMErix?

LYMErix became the first Lyme vaccine for humans approved in the United States. Although initial uptake was encouraging, enthusiasm declined over time.

Questions surrounding effectiveness, multiple-dose schedules, public confidence, and ongoing safety concerns gradually affected adoption.

Its withdrawal continues to influence how patients and clinicians discuss future vaccine programs.

Why was LYMErix discontinued?

Several factors appear to have contributed to discontinuation.

Low demand was likely influenced by cost, multiple required doses, questions about effectiveness, and broader public concern regarding vaccine safety.

Motta noted that misinformation about vaccine safety—including disputed claims involving autoimmune complications—may also have contributed to declining public confidence.1

Is there a Lyme disease shot for humans?

Many patients ask whether there is currently a Lyme disease shot for humans. At present, there is no widely available Lyme vaccine for humans in routine use in the United States, although several vaccine candidates continue to be studied.

The history of LYMErix continues to shape how patients think about future vaccine development.

Lyme vaccine safety, trust, and effectiveness

Public trust may ultimately determine whether future human Lyme vaccines succeed.

Patients frequently ask whether vaccines can prevent more than early Lyme disease rash and whether they reduce the risk of persistent or chronic manifestations.

Concerns about effectiveness, safety, transparency, and long-term outcomes continue to shape public opinion.

Readers interested in prevention strategies may also review Lyme disease prevention and discussions around alternative prevention approaches.

Editor’s perspective

I have remained concerned that vaccines designed primarily to prevent early manifestations of Lyme disease may not fully address questions surrounding chronic manifestations of illness.

I am not convinced that questions surrounding autoimmune complications after Lyme vaccination were ever completely resolved.

Frequently Asked Questions

Is there a Lyme disease vaccine for humans?

There is currently no widely available Lyme vaccine for humans in routine use in the United States, although newer vaccines continue to be investigated.

Is there a Lyme disease shot for humans?

No approved Lyme disease shot for humans is currently available for routine use in the United States, though new vaccines remain under development.

What happened to LYMErix?

LYMErix was introduced in the late 1990s and later withdrawn because of low demand and declining public confidence.

Why was LYMErix discontinued?

Low demand, multiple required doses, effectiveness concerns, cost, and safety debates all appear to have contributed.

Are new Lyme vaccines being developed?

Yes. Several vaccine candidates continue to be studied as researchers attempt to improve protection and public acceptance.

Clinical Takeaway

Questions about a Lyme vaccine for humans extend beyond efficacy alone.

The experience with LYMErix suggests that trust, transparency, effectiveness, and patient concerns may ultimately determine whether future vaccines gain acceptance.

Related Articles

Researchers race to develop a Lyme disease vaccine
Questions linger on Lyme vaccine efficacy
Could monoclonal antibodies prevent Lyme disease better than a vaccine?
Prevention of Lyme disease

References

  1. Motta M. Could concern about climate change increase demand for a Lyme disease vaccine in the U.S.? Vaccine. 2020.

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

SymptomsTestingCoinfectionsRecoveryPediatricPrevention

Related Posts

8 thoughts on “Lyme Vaccine for Humans: What Happened to LYMErix?”

  1. I would love to see a vaccine for those who are already suffering immensely from this horrible disease. People are not going to take a vaccine to prevent something that most people don’t understand. The only people who understand this disease are those who have been suffering for many years. I’m 62 and have had it for 32 years. I had 6 attachments. All filled on my pillow. I remember it well. But dismissed it because Lyme disease was not even being talked about. This is a neurological mess. My life is pretty much over.

  2. Some people were required to get the previous vaccine because they had outdoor occupations. They had no choice.

    Also, there was documented, published damage from that vaccine. In fact, current makers of lyme vaccines have said they removed those elements that caused an autoimmune condition. That is the opposite of the claims that anti-vaxxers and false claims were to blame.

  3. I was vaccine participant in 1995 LD from SmithKline Beecham. I almost died, the study docs denied my symptoms after 3 shots, lab changed ownership & became GlaGlaxoSmithKline etc… Its all for $ not facts! I still suffer daily, lost my marriage, my home & continue to suffer! DON’T GET LD VACCINE!

  4. No ! I do not trust lyme vaccine. I got the lymerix and now I have chronic lyme. How can you make a vaccine when there are so many strains ? This would not protect against coinfections either giving people a false sense of protection. It would also allow doctors to dismiss sick people.

Leave a Comment

Your email address will not be published. Required fields are marked *